Topic
Cannabinoids
61 published works
Canna Law Blog
Congress Wants to Hear from You on CBD by August 18th
Today’s public service announcement is that Congress wants to hear from you on a regulatory fix for cannabidiol (CBD) and other hemp-derived cannabinoid products. The request came down via the…
Canna Law Blog
Cannabinoid Folks, Pay Attention to Kratom
It seems as if there is a new cannabinoid product coming out every five minutes. Scratch that – it seems like there is a new cannabinoid coming out every five minutes.…
Tobacco Law Blog
Virginia’s New Hemp Regulations – How It Affects Businesses
By Christina Sava, Agustin Rodriguez, Kevin Andres Rodriguez
Virginia's new hemp-derived products statutes (Va. Code § 3.2-5145.1 et seq.) went into effect as of July 1, standing to drastically alter the availability of hemp-derived products in Virginia. What…
Canna Law Blog
So Long for THCA Products
Ever since Congress passed the Agricultural Improvements Act of 2018 (or 2018 Farm Bill), people have tried to find creative ways to sell intoxicating hemp-derived products. One example of this…
Kight on Cannabis
Did New York’s Office of Cannabis Management Just Overreach on Hemp Cannabinoids?
By Rod Kight
Although the New York Cannabis Control Board is permitted by law to prohibit certain products or classes of products derived from cannabinoid hemp, it remains unclear how it would prohibit "high THC…
Kight on Cannabis
How Is This Not Hemp? Peeking Under the Hood at a THCa Hemp Flower Production Facility
By Rod Kight
THCa Flower remains misunderstood and controversial. For that reason, I took to the field, literally and figuratively, and toured a THCa Flower production facility in my home state of North Carolina.
Budding Trends
Editors’ Roundtable: Predictions About the Upcoming Farm Bill
By Whitt Steineker, James W. Wright Jr., J. Hunter Robinson, Slates C. Veazey
Welcome to the latest installment of the Editors’ Roundtable, in which our editors – Whitt Steineker, Jay Wright, Hunter Robinson, and Slates Veazey – discuss cannabis issues in the news and take a stab at…
Kight on Cannabis
Rod Discusses Minor Cannabinoids and the DEA [Video]
By Rod Kight
This post contains the full-length video discussion I recently had about novel cannabinoids and the DEA with Christopher Ware, founder of KCA Laboratories, and Jody McGinness, Executive Director of the…
Cannabis Legal Highlights
Cannabis Legal Report—Week of March 1, 2023
By Elizabeth Gustafson, Tommy Tobin, Andrew Kline, Hanna Barker Mullin
Cannabis: In Focus DEA Classifies Two Lab-Derived Cannabinoids as Schedule I Washington Federal Judge Dismisses Suit Challenging Residency Requirements DEA Classifies Two Lab-Derived Cannabinoids as Schedule I The U.S. Drug…
Kight on Cannabis
Cannabinoid Breakdown- Analyzing the DEA’s Position on Novel Cannabinoids
By Rod Kight
This article breaks down the legal status of novel and mood-altering cannabinoids, including a discussion of the “synthetic versus natural” issue that is dominating much of the cannabis conversation in…